Kensey Nash seeks permission to conduct human trials of knee implant

02/24/2009 | Boston Globe (tiered subscription model), The

Kensey Nash has filed with the FDA an Investigational Device Exemption to conduct a human study on its cartilage-repair device, a biological knee implant designed to fix damaged cartilage. The device, which is made up of collagen and various minerals, could help avoid osteoarthritis and allow surgeons to reduce the number of knee-replacement surgeries, the company said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY